Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of “Moderate Buy” by Analysts

Option Care Health, Inc. (NASDAQ:OPCH) has received a consensus recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $37.4615.

OPCH has been the topic of several analyst reports. Citizens Jmp restated a “market outperform” rating and set a $38.00 price target (up from $36.00) on shares of Option Care Health in a report on Tuesday, January 13th. Barrington Research upped their target price on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a report on Friday, January 16th. Deutsche Bank Aktiengesellschaft increased their price target on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Jefferies Financial Group reissued a “buy” rating and issued a $37.00 price objective on shares of Option Care Health in a research report on Tuesday, January 13th. Finally, Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Tuesday, January 13th.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was acquired at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the acquisition, the director owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. This represents a 10.12% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Durable Capital Partners LP raised its holdings in shares of Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the period. Arrowstreet Capital Limited Partnership lifted its position in shares of Option Care Health by 17.3% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 4,001,307 shares of the company’s stock valued at $111,076,000 after buying an additional 590,913 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Option Care Health by 6.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 3,796,396 shares of the company’s stock worth $105,384,000 after acquiring an additional 235,413 shares during the period. Norges Bank bought a new position in shares of Option Care Health during the 2nd quarter worth $69,932,000. Finally, Jennison Associates LLC increased its holdings in Option Care Health by 145.6% in the 2nd quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock worth $69,450,000 after acquiring an additional 1,267,660 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Price Performance

OPCH opened at $35.33 on Wednesday. The firm’s fifty day moving average price is $32.56 and its two-hundred day moving average price is $29.78. The company has a market capitalization of $5.61 billion, a price-to-earnings ratio of 28.04, a P/E/G ratio of 2.16 and a beta of 0.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05. Option Care Health has a 1 year low of $24.24 and a 1 year high of $36.80.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.